195 related articles for article (PubMed ID: 21569052)
1. Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis.
Govendir M; Hanger J; Loader JJ; Kimble B; Griffith JE; Black LA; Krockenberger MB; Higgins DP
J Vet Pharmacol Ther; 2012 Apr; 35(2):147-54. PubMed ID: 21569052
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus).
Black LA; McLachlan AJ; Griffith JE; Higgins DP; Gillett A; Krockenberger MB; Govendir M
J Vet Pharmacol Ther; 2013 Oct; 36(5):478-85. PubMed ID: 23157306
[TBL] [Abstract][Full Text] [Related]
3. Assessment of florfenicol as a possible treatment for chlamydiosis in koalas (Phascolarctos cinereus).
Budd C; Flanagan C; Gillett A; Hanger J; Loader JJ; Govendir M
Aust Vet J; 2017 Sep; 95(9):343-349. PubMed ID: 28845567
[TBL] [Abstract][Full Text] [Related]
4. Clinical comparison of five anti-chlamydial antibiotics in koalas (Phascolarctos cinereus).
Booth R; Nyari S
PLoS One; 2020; 15(7):e0236758. PubMed ID: 32730301
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of chloramphenicol, florfenicol and enrofloxacin against Chlamydia pecorum isolated from koalas (Phascolarctos cinereus).
Black LA; Higgins DP; Govendir M
Aust Vet J; 2015 Nov; 93(11):420-3. PubMed ID: 26412342
[TBL] [Abstract][Full Text] [Related]
6. Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease.
Robbins A; Loader J; Timms P; Hanger J
PLoS One; 2018; 13(12):e0209679. PubMed ID: 30589897
[TBL] [Abstract][Full Text] [Related]
7. PREVALENCE AND PATHOLOGIC FEATURES OF CHLAMYDIA PECORUM INFECTIONS IN SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS).
Speight KN; Polkinghorne A; Penn R; Boardman W; Timms P; Fraser T; Johnson K; Faull R; Bate S; Woolford L
J Wildl Dis; 2016 Apr; 52(2):301-6. PubMed ID: 26967132
[TBL] [Abstract][Full Text] [Related]
8. Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus).
Markey B; Wan C; Hanger J; Phillips C; Timms P
Vet Microbiol; 2007 Mar; 120(3-4):334-42. PubMed ID: 17178441
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and clinical significance of Chlamydia infection in island and mainland populations of Victorian koalas (Phascolarctos cinereus).
Patterson JL; Lynch M; Anderson GA; Noormohammadi AH; Legione A; Gilkerson JR; Devlin JM
J Wildl Dis; 2015 Apr; 51(2):309-17. PubMed ID: 25588005
[TBL] [Abstract][Full Text] [Related]
10. Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus).
Griffith JE; Higgins DP; Li KM; Krockenberger MB; Govendir M
J Vet Pharmacol Ther; 2010 Dec; 33(6):595-604. PubMed ID: 21062313
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology.
Kollipara A; George C; Hanger J; Loader J; Polkinghorne A; Beagley K; Timms P
Vaccine; 2012 Feb; 30(10):1875-85. PubMed ID: 22230583
[TBL] [Abstract][Full Text] [Related]
12. A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus).
Waugh C; Khan SA; Carver S; Hanger J; Loader J; Polkinghorne A; Beagley K; Timms P
PLoS One; 2016; 11(1):e0146934. PubMed ID: 26756624
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antigen detection and quantitative PCR in the detection of chlamydial infection in koalas (Phascolarctos cinereus).
Hanger J; Loader J; Wan C; Beagley KW; Timms P; Polkinghorne A
Vet J; 2013 Mar; 195(3):391-3. PubMed ID: 22944246
[TBL] [Abstract][Full Text] [Related]
14. EPIDEMIOLOGY OF CHLAMYDIA-INDUCED REPRODUCTIVE DISEASE IN MALE KOALAS (
Hulse LS; Beagley K; Ellis W; Fitzgibbon S; Gillett A; Barth B; Robbins A; Pyne M; Larkin R; Johnston SD
J Wildl Dis; 2020 Jan; 56(1):82-92. PubMed ID: 31329524
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population.
Nyari S; Waugh CA; Dong J; Quigley BL; Hanger J; Loader J; Polkinghorne A; Timms P
PLoS One; 2017; 12(12):e0190114. PubMed ID: 29281731
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study on antibacterial treatments for koalas infected with Chlamydia pecorum.
Chen CJ; Casteriano A; Green AC; Govendir M
Sci Rep; 2023 Aug; 13(1):12670. PubMed ID: 37542093
[TBL] [Abstract][Full Text] [Related]
17. The effect of Chlamydia infection on koala (Phascolarctos cinereus) semen quality.
Hulse L; Beagley K; Larkin R; Nicolson V; Gosálvez J; Johnston S
Theriogenology; 2021 Jun; 167():99-110. PubMed ID: 33813053
[TBL] [Abstract][Full Text] [Related]
18. THE PARADOX OF EUTHANIZING KOALAS (PHASCOLARCTOS CINEREUS) TO SAVE POPULATIONS FROM ELIMINATION.
Wilson DP; Craig AP; Hanger J; Timms P
J Wildl Dis; 2015 Oct; 51(4):833-42. PubMed ID: 26280878
[TBL] [Abstract][Full Text] [Related]
19. Using quantitative polymerase chain reaction to correlate Chlamydia pecorum infectious load with ocular, urinary and reproductive tract disease in the koala (Phascolarctos cinereus).
Wan C; Loader J; Hanger J; Beagley K; Timms P; Polkinghorne A
Aust Vet J; 2011 Oct; 89(10):409-12. PubMed ID: 21933169
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
Nyari S; Khan SA; Rawlinson G; Waugh CA; Potter A; Gerdts V; Timms P
PLoS One; 2018; 13(6):e0200112. PubMed ID: 29953523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
